Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years May-Bente Bengtson, Camilla.

Slides:

Advertisements

Similar presentations

Volume 151, Issue 4, Pages e4 (October 2016)

Advertisements

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Work disability in inflammatory bowel disease

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe Peter.

Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008 Peter Laszlo Lakatos,

IBD in the elderly population: Results from a population-based study in Western Hungary, 1977��2008 Peter Laszlo Lakatos, Gyula David, Tunde Pandur,

How do psychological variables influence coping strategies in inflammatory bowel disease? Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.

Inger Camilla Solberg, Morten H

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review Doron Boltin, Zohar Levi, Marisa Halpern,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

YouTube® and inflammatory bowel disease

Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease,

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature Gurhan.

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud, Alexander C. Ford,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series Erik Mooiweer,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Expression and functional analysis of intestinal organic cation/l-carnitine transporter (OCTN) in Crohn's Disease Marc Girardin, Serge Dionne, Philippe.

Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells Ashok Kumar.

Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants T. Felekis, K.H. Katsanos, C.D. Zois,

Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study Livia.

Serum prohepcidin levels in chronic inflammatory bowel diseases

Charlotte de Bie, Angelika Kindermann, Johanna Escher

N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard

Fatal Colonic Perforation in a Pregnant with Behçet's Disease

Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim Journal.

Public awareness of Crohn's disease and ulcerative colitis: A national survey Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature Dana Duricova, Johan Burisch,

Reply Gastroenterology

Paula Borralho, Ana Vieira, João Freitas, Paula Chaves, Jorge Soares

Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010 Tine Jess, Morten Frisch, Jacob Simonsen

Volume 151, Issue 4, Pages e4 (October 2016)

Inger Camilla Solberg, Morten H

Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis Niels Teich, Tobias Klugmann Journal of.

Seth Lipka, Seymour Katz, Lev Ginzburg Journal of Crohn's and Colitis

Osteoporosis in inflammatory bowel disease

Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease,

Pediatric pulmonary Crohn's disease: More frequent than expected

Suppurative granulomatous inflammation in the ileo-anal pouch

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Pathogenic Escherichia coli in inflammatory bowel diseases

Volume 132, Issue 2, Pages (February 2007)

Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation Sjoerd F. Bakker,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

Fernando Fernández-Bañares, Antonio Salas, Maria Esteve

Reply Gastroenterology

Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.

Does active smoking really influence the course of Crohn's disease

Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms Mariëlle.

Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E

Mathilde Wagner, Jeremie H

Surgical management of gluteal metastatic cutaneous Crohn's disease

Bowel sonography in occlusive Crohn's disease

The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China Yue Li, Li-fan Zhang, Xiao-qing.

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn A. Moum, Morten H. Vatn

Meenakshi Bewtra, Chinyu Su, James D. Lewis

Presentation transcript:

Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years May-Bente Bengtson, Camilla Solberg, Geir Aamodt, Jostein Sauar, Jørgen Jahnsen, Bjørn Moum, Idar Lygren, Morten H. Vatn Journal of Crohn's and Colitis Volume 3, Issue 2, Pages 92-99 (June 2009) DOI: 10.1016/j.crohns.2008.11.002 Copyright © 2008 European Crohn's and Collitis Organisation Terms and Conditions

Figure 1 Age at diagnosis of Crohn's disease in familial and sporadic cases in a Norwegian population based cohort. The mean difference in age at diagnosis between familial and sporadic cases was 10.7 years, p=0.002. Journal of Crohn's and Colitis 2009 3, 92-99DOI: (10.1016/j.crohns.2008.11.002) Copyright © 2008 European Crohn's and Collitis Organisation Terms and Conditions

Figure 2 Inflammatory bowel disease among 1st degree relatives of UC at inclusion and ten years follow up in a Norwegian population-based cohort. Journal of Crohn's and Colitis 2009 3, 92-99DOI: (10.1016/j.crohns.2008.11.002) Copyright © 2008 European Crohn's and Collitis Organisation Terms and Conditions

Figure 3 Inflammatory bowel disease among 1st degree relatives of CD at inclusion and ten years follow up in a Norwegian population-based cohort. Journal of Crohn's and Colitis 2009 3, 92-99DOI: (10.1016/j.crohns.2008.11.002) Copyright © 2008 European Crohn's and Collitis Organisation Terms and Conditions